aTyr Pharma | LIFE - Pre Tax Profit


aTyr Pharma reported $-153K in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -6.26M 1.52M Dec/2025
Ardelyx USD -37.6M 37.2M Mar/2026
aTyr Pharma USD -153K 25.59M Mar/2026
Biogen USD 647.3M 269.6M Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Cipla INR 10.82B 3.33B Jun/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -7.66M 64.51M Mar/2026
CSL USD 2.61B 1.21B Dec/2025
Curis USD -24.2M 43.56M Mar/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Grifols EUR 257.85M 190.87M Dec/2024
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
United Therapeutics USD 372.7M 54.4M Jun/2026